Intra-articular injection of autologous adipose-derived stem cells or stromal vascular fractions: are they effective for patients with knee osteoarthritis? A systematic …
Background: Intra-articular injection of adipose-derived stem cells, which are divided into
adipose-derived mesenchymal stem cells (ASCs) and adipose-derived stromal vascular …
adipose-derived mesenchymal stem cells (ASCs) and adipose-derived stromal vascular …
Clinical and magnetic resonance imaging outcomes after microfracture treatment with and without augmentation for focal chondral lesions in the knee: a systematic …
LM Fortier, DM Knapik, SP Dasari… - … American Journal of …, 2023 - journals.sagepub.com
Background: Focal cartilage lesions represent a common source of knee pain and disability,
with the potential for the development and progression of osteoarthritis. Currently …
with the potential for the development and progression of osteoarthritis. Currently …
Aragonite-based scaffold versus microfracture and debridement for the treatment of knee chondral and osteochondral lesions: results of a multicenter randomized …
Background: Lesions of the articular cartilage, with or without involvement of the
subchondral bone, are a common cause of pain and dysfunction in the knee. Although …
subchondral bone, are a common cause of pain and dysfunction in the knee. Although …
A randomized trial of autologous chondrocyte implantation versus alternative forms of surgical cartilage management in patients with a failed primary treatment for …
Background: There are limited randomized controlled trials with long-term outcomes
comparing autologous chondrocyte implantation (ACI) versus alternative forms of surgical …
comparing autologous chondrocyte implantation (ACI) versus alternative forms of surgical …
Empfehlungen der AG klinische geweberegeneration zur behandlung von knorpelschäden am kniegelenk
The Working Group of the German Orthopedic and Trauma Society (DGOU) on Tissue
Regeneration has published recommendations on the indication of different surgical …
Regeneration has published recommendations on the indication of different surgical …
[HTML][HTML] Charting a quarter-century of commercial cartilage regeneration products
Functional cartilage regeneration remains difficult to achieve despite decades of research.
Dozens of commercial products have been proposed, with each targeting different facets of …
Dozens of commercial products have been proposed, with each targeting different facets of …
Autologous matrix-induced chondrogenesis is effective for focal chondral defects of the knee
Focal chondral defects of the knee are common and their management is challenging. This
study investigated the efficacy and safety of Autologous Matrix-Induced Chondrogenesis …
study investigated the efficacy and safety of Autologous Matrix-Induced Chondrogenesis …
[HTML][HTML] A systematic review on Autologous Matrix Induced Chondrogenesis (AMIC) for chondral knee defects
JJS Ong, SF Tan, T Kurien - The Knee, 2024 - Elsevier
Background Chondral defects of the knee can be identified in up to 60% of patients
undergoing knee arthroscopy. The use of Autologous Matrix Induced Chondrogenesis …
undergoing knee arthroscopy. The use of Autologous Matrix Induced Chondrogenesis …
The effect of lesion size on pain and function in patients scheduled for cartilage surgery of the knee
PH Randsborg, A Årøen, C Owesen - Cartilage, 2022 - journals.sagepub.com
Objective Despite an increased interest in treatment options for cartilage lesions of the knee,
the relationship between lesion characteristics and the symptoms they elicit is not well …
the relationship between lesion characteristics and the symptoms they elicit is not well …
Chitosan‐based scaffold augmentation to microfractures: Stable results at mid‐term follow‐up in patients with patellar cartilage lesions
Purpose Patellar cartilage lesions are a frequent and challenging finding in orthopaedic
clinical practice. This study aimed to evaluate a chitosan‐based scaffold's mid‐term clinical …
clinical practice. This study aimed to evaluate a chitosan‐based scaffold's mid‐term clinical …